Approvals/CIMA-AEMPS/BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Glaxosmithkline Trading Services Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 69b7d085d88b5d66
Drug Cima Aemps Name: BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1251948002
Holder Company Name: Glaxosmithkline Trading Services Limited
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-trading-services-limited
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2025-07-30
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 100 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Glaxosmithkline Trading Services Limited
Company Detail Path: /organization/glaxosmithkline-trading-services-limited

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jul 30, 2025

Approval ID

69b7d085d88b5d66

Type

Standard